4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-025381
Director sold 1,270 shares at $27.67 ($35,143)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Heyman Richard A. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-15 | Sale : show line 1 in the form 10b5-1 | −1,270 | $27.67 | $35,143 | 124,490 | D |
| Open-market sales · 1,270 sh · avg $27.67 · $35,143 | ||||||
Loading xslF345X05/form4-10172024_091039.xml…